Evidence map›Paper›PMID 25903649›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2015

Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.

Julia V Busik, Maria B Grant

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Julia V BusikFrom the Department of Physiology, Michigan State University, East Lansing (J.V.B.); and Departments of Ophthalmology and Cellular and Integrative Physiology, Indiana University, Indianapolis (M.B.G.). busik@msu.edu.
Maria B GrantFrom the Department of Physiology, Michigan State University, East Lansing (J.V.B.); and Departments of Ophthalmology and Cellular and Integrative Physiology, Indiana University, Indianapolis (M.B.G.).

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
NITRIC OXIDE IN THE PATHOGENESIS OF DIABETIC RETINOPATHYR01EY012601 · NEI · UNIVERSITY OF FLORIDA · PI Julia V Busik, Maria Bartolomeo Grant · 1998 to 2026
$9.6M
Dyslipidemia and Diabetic RetinopathyR01EY016077 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BUSIK, JULIA V · 2005 to 2025
$6.3M
Targeting the IGF-1 System in Retinal AngiogenesisR01EY007739 · NEI · UNIVERSITY OF FLORIDA · PI ABCOUWER, STEVEN F, GRANT, MARIA BARTOLOMEO · 1995 to 2015
$5.4M
NO Dysregulation of the Peripheral Clock in Diabetic ComplicationsR01DK090730 · NIDDK · UNIVERSITY OF FLORIDA · PI GRANT, MARIA BARTOLOMEO · 2010 to 2013
$1.3M
HORMONES &NEOVASCULARIZATION IN DIABETIC RETINOPATHYR29EY007739 · NEI · UNIVERSITY OF FLORIDA · PI GRANT, MARIA B · 1989 to 1993
–
NEI NIH HHS EY-01-6077NEI NIH HHS EY-07739NEI NIH HHS EY-12601NEI NIH HHS R01 EY007739NEI NIH HHS R01 EY012601NIDDK NIH HHS DK-09-0730NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK090730
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NanoparticlesWnt Signaling PathwayAnimalsCorneaCorneal NeovascularizationHumansLactic AcidPolyglycolic AcidReceptors, LDLRetinal NeovascularizationRetinal VesselsTransfectionWnt3A ProteinLactic AcidPolyglycolic AcidReceptors, LDLWnt3A Protein

Identifiers

PMID25903649
PMCPMC4428600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.